Can-Fite Biopharma Ltd Sponsored ADR (Israel)

0.850000.00Vol 47.83K1Y Perf -60.28%
Aug 9th, 2022 15:54 DELAYED
BID0.8411 ASK0.8500
Open0.8800 Previous Close0.8500
Pre-Market- After-Market0.86
 - -  0.01 1.18%
Target Price
5.00 
Analyst Rating
Strong Buy 1.00
Potential %
488.24 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★+     48.41
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
3.85 
Earnings Rating
Strong Buy
Market Cap23.11M 
Earnings Date
25th Aug 2022
Alpha-0.05 Standard Deviation0.19
Beta1.74 

Today's Price Range

0.84020.8800

52W Range

0.78002.60

5 Year PE Ratio Range

-2.60-1.20

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Strong Sell
Performance
1 Week
0.00%
1 Month
-5.56%
3 Months
1.18%
6 Months
-26.72%
1 Year
-60.28%
3 Years
-68.05%
5 Years
-96.30%
10 Years
-

TickerPriceChg.Chg.%
CANF0.85000.00000.00
AAPL164.920.05000.03
GOOG117.50-0.6400-0.54
MSFT282.301.98000.71
XOM90.591.64001.84
WFC43.400.21000.49
JNJ170.18-0.0200-0.01
FB196.640.99000.51
GE74.93-0.2500-0.33
JPM115.381.03000.90
 
ProfitabilityValueIndustryS&P 500US Markets
-
-1 433.10
-1 433.10
-1 115.80
-
RevenueValueIndustryS&P 500US Markets
660.00K
0.02
-
-
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.12-0.0925.00
Q04 2021-0.18-0.19-5.56
Q03 2021-0.10-0.19-90.00
Q02 2021-0.12-0.19-58.33
Q01 2021-0.17-0.1229.41
Q04 2020-0.13-0.30-130.77
Q03 2020-0.25-0.244.00
Q02 2020-0.28-0.30-7.14
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.0925.00Positive
9/2022 QR-0.0918.18Positive
12/2022 FY-0.342.86Positive
12/2023 FY-0.13-44.44Negative
Next Report Date25th Aug 2022
Estimated EPS Next Report-0.09
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume47.83K
Shares Outstanding27.19K
Shares Float27.19M
Trades Count212
Dollar Volume41.11K
Avg. Volume196.27K
Avg. Weekly Volume51.17K
Avg. Monthly Volume150.68K
Avg. Quarterly Volume386.96K

Can-Fite Biopharma Ltd Sponsored ADR (Israel) (AMEX: CANF) stock closed at 0.85 per share at the end of the most recent trading day (a 0% change compared to the prior day closing price) with a volume of 47.83K shares and market capitalization of 23.11M. Is a component of indices and it is traded on AMEX exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 8 people. Can-Fite Biopharma Ltd Sponsored ADR (Israel) CEO is Pnina Fishman.

The one-year performance of Can-Fite Biopharma Ltd Sponsored ADR (Israel) stock is -60.28%, while year-to-date (YTD) performance is -34.11%. CANF stock has a five-year performance of -96.3%. Its 52-week range is between 0.78 and 2.6, which gives CANF stock a 52-week price range ratio of 3.85%

Can-Fite Biopharma Ltd Sponsored ADR (Israel) currently has a PE ratio of -0.90, a price-to-book (PB) ratio of 1.81, a price-to-sale (PS) ratio of 33.23, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -105.50%, a ROC of -163.61% and a ROE of -168.50%. The company’s profit margin is -%, its EBITDA margin is -1 433.10%, and its revenue ttm is $660.00 Thousand , which makes it $0.02 revenue per share.

Of the last four earnings reports from Can-Fite Biopharma Ltd Sponsored ADR (Israel), there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.09 for the next earnings report. Can-Fite Biopharma Ltd Sponsored ADR (Israel)’s next earnings report date is 25th Aug 2022.

The consensus rating of Wall Street analysts for Can-Fite Biopharma Ltd Sponsored ADR (Israel) is Strong Buy (1), with a target price of $5, which is +488.24% compared to the current price. The earnings rating for Can-Fite Biopharma Ltd Sponsored ADR (Israel) stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Can-Fite Biopharma Ltd Sponsored ADR (Israel) has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Can-Fite Biopharma Ltd Sponsored ADR (Israel) has a Neutral technical analysis rating based on Technical Indicators (ADX : 30.58, ATR14 : 0.05, CCI20 : 81.44, Chaikin Money Flow : -0.19, MACD : -0.01, Money Flow Index : 58.28, ROC : 0.00, RSI : 43.47, STOCH (14,3) : 55.19, STOCH RSI : 0.52, UO : 41.69, Williams %R : -44.81), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Can-Fite Biopharma Ltd Sponsored ADR (Israel) in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma Ltd is a clinical-stage biopharmaceutical company. The company is focused on developing orally bioavailable small molecule therapeutic products for the treatment of autoimmune inflammatory indications, oncology and liver diseases as well as sexual dysfunction. Its platform technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention. The company's pipeline drugs are synthetic, specific agonists and allosteric modulators targeting the A3AR. All drugs are orally bioavailable with an excellent safety profile.

CEO: Pnina Fishman

Telephone: +972 39241114

Address: 10 Bareket Street, Kiryat Matalon, Petah-Tikva 4951778, , IL

Number of employees: 8

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

75%25%

Bearish Bullish

54%46%

TipRanks News for CANF

Wed, 06 Apr 2022 10:25 GMT Can-Fite BioPharma (CANF) Receives a Buy from H.C. Wainwright

- TipRanks. All rights reserved.

Wed, 09 Feb 2022 09:03 GMT Analysts Offer Insights on Healthcare Companies: and Can-Fite BioPharma (CANF)

- TipRanks. All rights reserved.

News

Stocktwits